AstraZeneca stops lung cancer trial early, after star drug Tagrisso induces 'overwhelming' efficacy

AstraZeneca stops lung cancer trial early, after star drug Tagrisso induces 'overwhelming' efficacy

Source: 
Endpoints
snippet: 

A pivotal lung cancer trial testing Tagrisso, AstraZeneca’s bestselling oncology therapy, has been halted due to “overwhelming” efficacy.